News
Detailed price information for Bioage Labs Inc (BIOA-Q) from The Globe and Mail including charting and trades.
BioAge Labs (BIOA) announced that the first participant has been dosed in a Phase 1 clinical trial evaluating BGE-102, a structurally novel, ...
Detailed price information for Bioage Labs Inc (BIOA-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback